Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131020) titled 'Study on the Mechanism of Yifei Moxibustion Improving Immune Function in COPD Based on Plasma Exosome miRNAs' on Aug. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Henan University of Traditional Chinese Medicine
Condition:
Stable COPD Patients
Intervention:
Behavioral: Yifei moxibustion
Drug: Conventional Western medicine treatment
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 11, 2024
Target Sample Size: 120
Countries of Recruitment:
China...